Gyneco Flashcards
Sudden switch from negative to positive feedback in menstrual cycle
Ovulation
LH surge to ovulation
36 h
Duration of luteal phase
Fixed 14 d
Duration of follicular phase
Variable
Cervical spinnbarkeit in proliferative phase
8-10 cm
Cervical mucus spinnbarkeit in secretory phase
1-2 cm
Age of menarche
10-15 y
Cycle duration
28 +/- 7 d
Blood loss per cycle
25-80 ml
1-6 d
Stages of puberty
Adrenarche Gonadarche Thelarche Pubarche Menarche
Thelarche to menarche
2y
Criteria for PMS Dx
1 affective + 1 somatic symptom
During the 5 d before menses
In each of the 3 prior menses
Relieved within 4 d of menses
1st line PMS Tx
Exercise CBT B6 CHC low dose SSRI during luteal phase
2nd line PMS Tx
Estradiol patch + micronized progestrone
LNG-IUS
Higher dose SSRIs (continual/luteal)
3rd line PMS Tx
GnRH analogues
+ add-back HRT
4th line PMS Tx
Surgery
+/- HRT
PMS symptoms
1 of: Depression Anxiety Irritability Anger Confusion Social withdrawal \+ 1 of: Breast tenderness Bloating Limb edema Headache
Premenstrual dysphoric disorder symptoms
PMS symptoms + Decreased interest in activities Difficulty concentrating Lethargy Change in appetite Hypersomnia/insomnia Feeling overwhelmed Joint/muscle pain Weight gain
PDD criteria
At least 5 symptoms
Most cycles of the last year
Structural causes of AUB
PALM Polyps Adenomyosis Leiomyoma Malignancy/hyperplasia
Non-structural AUB
COEIN coagulopathy Ovulatory dysfunction Endometrial Iatrogenic Not yet classified
Regular menses
Cycle to cycle variability less than 20 days
Irregular: 20 d or more
Heavy bleeding
80 ml or more
8 d or more
Bleeding that significantly affects quality of life
Postmenopausal bleeding
Bleeding more than 1 y after menopause
Drug causing genital pruritis
OCP (progesterone)
REMEMBER TO ASK in chronic pelvic pain
Hx of sexual abuse/assault
1st/2nd Trimester bleeding DDx
EP Abortion Trauma Coagulopathy Infection
1st/2nd T bleeding investigations
CBC
Blood group/screen
B-hCG
U/S
Detection of pregnancy by TVS IF B-hCG:
1500
Detection of pregnancy by transabdominal sono if beta:
6500
Indications for endometrial bleeding
PMB AUB+ age>40 AUB+ RF for endometrial cancer AUB+ failure of medical treatment Significant intermenstrual bleeding AUB+ infrequent menses
Recovery time regarding hysterectomy approach
Fastest: vaginal
Then: laparoscopic
Last: abdominal
The most common cause of primary amenorrhea
Mullerian agenesis
Abnormal sex chromosomes (turner)
Functional hypothalamic amenorrhea
The most common cause of secondary amenorrhea
Functional hypothalamic amenorrhea
1st question in amenorrhea
Primary or secondary?
1st question in primary amenorrhea
Secondary sexual characteristics? (Breasts)
Primary amenorrhea with normal secondary sexual characteristics
Karyotype
1ْ amenorrhea + 2ْ sexual characteristics + XX karyotype
*abnormal pelvis Imperforated hymen Transverse vaginal septum Cervical agenesis Müllerian agenesis * normal pelvis Hypothyroidism Hyperprolactinemia PCOS Hypothalamic dysfunction
1ْ amenorrhea + breast + XY Karyotype
AIS
1ْ amenorrhea, no breast
FSH/LH
1ْ amenorrhea, no 2ْ , high FSH
Hypergonadotropic hypogonadism Karyotype -XO -XX -XY
1ْ amenorrhea, no 2ْ , low FSH
Hypogonadotropic hypogonadism -constitutional delay -HPA axis abnormality • GnRH deficiency • kallman • head injury • pituitary adenoma/tumor • DM1 • systemic disorders (IBD, JRA, chronic infection)
1st step in 2ْ anenorrhea
Beta
2ْ amenorrhea with negative beta
Prolactin
Normal prolactin amount
< 20 ng/dL
If high prolactin
> 100 ng/dL, CT head
TSH
2ْ amenorrhea, negative beta, normal PRL
Progestin challenge
2ْ amenorrhea, negative beta, normal PRL, no W/D bleeding with progestin challenge
POI Uterine defect Asherman HP axis dysfunction Excessive androgens Excessive progesterones
2ْ amenorrhea, no beta, nl PRL, W/D bleeding
FSH/LH
2ْ amen, no beta, nl PRL, W/D bleed, high FSH/LH
PCOS
Hyperandrogenism (androgens)
2ْ amen, no beta, nl PRL, W/D bleed, low/nl FSH/LH
HP axis dysfunction
• weight loss
• excessive exercise
• systemic disease
In case if HP axis dysfunction
MRI hypothalamus
MRI pituitary
Other pituitary hormones measurement
AIS Mx
Gonadal resection after puberty
Psychological counselling
Creation of neovagina
Cervical agenesis Mx
Suppression
Ultimately hysterectomy
Müllerian dysgenesis
Psychological counselling
Neo-vagina
Confirm normal urinary system and spine
Asherman Mx
HSG
SHG
Hysteroscopy & excision of synechiae
2ْ amenorrhea with HP axis dysfunction Mx
CHC to decrease the risk of osteoporosis
POF Mx
Screen (DM, hypothyroidism, hypocortisolism)
E+P to decrease osteoporosis
( can use OCP after induction of puberty)
HyperPRL
MRI/CT head
• if demonstrable lesion: surgery
• if no demonstrable lesion: bromocriptine, cabergoline (if fertility desired)
CHC if no fertility desired
Unpredictable AUB
Ovulatory dysfunction
Malignancy/hyperplasia
Regular heavy AUB
Adenomyosis
Leiomyoma,sm
Endometrial
Coagulopathy
Regular cycles, intermenstrual AUB
Polyp
1st question in AUB
Regular?
If regular bleed, 2nd question?
Heavy?
Definition of 1ْ amenorrhea
No menses by age 13 (if no 2ْ sexual characteristics)
No menses by age 15 (with 2ْ)
No menses 2 yr after thelarche
Definition of 2ْ amenorrhea
No menses for > 6 mo
No menses for 3 cycles
3 questions to ask in AUB
Regular?
Heavy?
Intermenstrual bleeding?
AUB, Polyp Dx, Mx
TVS
SHG
Polypectomy
AUB, Adenomyosis
TVS
MRI
AUB, Leiomyoma
TVS
SHG
Hysteroscopy
AUB, Malignancy/hyperplasia
TVS
Endometrial Bx
AUB, Coagulopathy
CBC Coagulation profile vWF Ristocetin Factor VIII Mx OCP Mirena IUD Endometrial ablation
AUB, ovulatory
Beta Ferritin FSH/LH PRL Androgens ( free test, DHEA, 17-oh prog) Progesterone TFT Pelvic U/S
AUB, endometrial
Bx
Mx: tranex, hormonal, Mirena IUD, endometrial ablation
AUB, iatrogenic
TVS
Review meds
Tx of AUB
Resuscitate
Underlying
Medical
Surgical (endometrial ablation, hysterectomy)
Medication for mild AUB
NSAIDs Antifibrinolytics at time if menses Combined OCP Progestin (10-14d/m or q 3 mo) Mirena IUD Danazol Correct anemia
Medication for acute, severe AUB
Fluid Consider admission •Estrogen IV q 4h x 24 h + Gravol •antifibrinolytic IV q8 h •OCP, TID x 7d, then, OD x 3wk + Gravol
Then
Monophasic OCP x several months
Primary dysmenorrhea associati
Dyspareunia
AUB
Infertility
Mx of 1ْ dysmenorrhea
NSAIDs
OCP
Investigations for dyspareunia
Bimanual exam +/- U/S Laparoscopy Hysteroscopy Infection screening
RFs for endonetriosis
FHx
Obstructive anomalies
Nulliparity
Age> 25
Triad of endometriosis
Dysmenorrhea
Dyspareunia
Dyschezia
Definite Dx of endometriosis
Laparoscopy and Bx (not required)
CA-125 (increased but not to be used for Dx)
Mainstay if endometriosis management
Menstrual suppression
1st line in suspected endometriosis
NSAIDs+
CHC (best continuous)
Progestin alone
No response to 1st line Tx of endometriosis
Either: •2nd line: GnRH + addback progestin IUS Danazol • laparoscopic Dx and Tx
No response to 2nd line or laparoscopic Tx
Reconsider Dx
Chronic pain management
Definitive Tx for endometriosis
BSO
Best time to become pregnant in endometriosis
Immediately after laparoscopic conservative surgery
If no plan to become pregnant post-op: medical suppression
Size of uterus in adenomyosis
<14 cm
Halban sign
Adenomyosis
Adenomyosis Dx
Clinical+/-
U/S
MRI
Bx
Adenomyosis Tx
Iron Analgesics, NSAIDs OCP MPA GnRH Mirena Danazol
Definitive Tx for adenomyosis
Hysterectomy
Fibroid malignant potential
1/1000
Consideration of malignancy in fibroids
If enlarging in post-menopausal women
Most common symptom of fibroids
Asymptomatic
AUB
Most symptomatics: submucosal
Leiomyoma investigations
CBC U/S SHG (to differentiate SM myoma from polyps) Endometrial Bx (if AUB > 40) MRI (preoperative planning)
Tx indications for fibroid
Symptomatic
Intracavitary
Conservative approach for myoma if
Minimal symptoms < 6-8 cm Stable in size Not submucosal Pregnant
Myoma in pregnant women
Watch and wait
F/U U/S if symptoms progress
Best to avoid operating on it
If myoma with AUB
NSAIDs (anti PG)
Tranex
OCP
MPA
GnRH (often pre-myomectomy/hysterectomy, or to bridge to menopause + addback)
Ulipristal acetate
Uterine artery embolization (not for women considering childbirth)
Myomectomy
Hysteroscopic resection+ endometrial ablation (if AUB-sm)
Hysterectomy
Ulipristal actate
Progesterone receptor antagonist
Causes endometrial changes, reversible with D/C
Most effective EPC
Postcoital IUD
Efficacy of transdermal contraceptive patches decreased in women weighing
> 90 kg
Time of starting hormonal contraceptive
Any time during the cycle
Best: within 5 d of LMP
Required exams before starting hormonal contraceptives
Breast exam
BP
F/U at 6 wk
OCP on ovary
Decreased cyst decelopment
Decreased cancer
OCP on endometrium
Decreased cancer
OCP on breast
Decreased benign disease
OCP on bone
Osteoporosis protection
OCP on liver
Adenoma (est)
Drugs decreasing efficacy of OCP
Rifampin Phenobarbital Phenytoin Griseofulvin Primidone St John’s Wort
OCP in pregnancy and lactation
Absolute contra in pregnancy
Not recommended until 6 wk postpartum
3 mo postpartum if breastfeeding
May decrease milk production
Breakthrough bleeding with low-dose OCPs
If longer than 3 mo, switch to higher estrogen content
Progestin in Yasmin/Yas
Drospirenone: antimineralocorticoid, antiandrogenic
Contra of Yas/Yasmin
Renal/adrenal insufficiency (hyperkalemia)
Check K if also on: ACEI, ARB, K sparing diuretics, heparin
Contraceptives that must be taken at the same time everyday
POP
POP contra
None
Suitable hormonal contraceptive for postpartum women
POP
Hormonal contraceptives producing functional ovarian cyst
POP
Hormonal method with highest failure rate
POP
Missed 1 OCP pill in <24h
1 ASAP
The next pill at the usual
Miss >1 pill in a row in 1st wk
1 ASAP
Continue 1 pill/d until the end of the pack
+ back-up contra for 7 d
+/- EPC
Miss 2 pills in 2nd or 3rd wk
1 ASAP
Continue 1 pill daily until the end of pack
No placebo, No free interval
Start next pack immediately
Miss 3 or more pills in 2nd or 3rd wk
1 ASAP 1 pill daily until the end of the pack No placebo, no free interval Start the next pack immediately Back-up contra for 7 days \+/- EPC
No need for back-up in case of missed OCP
Missed 1 pill in <24 h
Missed 2 pills in 2nd or 3rd wk
Need for back-up in case of missed OCPs
Miss more than 1 pill in a row in 1st wk
Miss 3 or more pills in 2nd or 3rd wk
Summary of 1st wk
• miss 1 pill <24h
1 ASAP + continue
• miss 2 or more
1 ASAP + continue + back-up 7d +/- EPC
Summary of 2nd-3rd wk
• miss 1 pill
1 ASAP, + continue
• miss 2 pills
1 ASAP + continue + next pack immediately
• miss 3 or more
1 ASAP + continue + next pack immediately + back-up 7 d +/- EPC
Timing of MPA after delivery
Immediately (BF/ non-BF)
Timing of MPA in usual cases
Within 5 d of beginning of normal menses
MPA on bones
Decreased bone density(may be reversible)
Encourage vit D, Ca, daily exercise
Restoration of fertility after MPA
Up to 9 mo
Missed POP
If > 3 h, back-up for at least 48 h
Missed MPA + negative beta
Give next injection + back-up 7 d +
• intercourse in last 5d, EPC
•intercourse 5-14 d ago, beta in 3 wk
•intercourse >14 d ago, nothing more
Yuzpe combination
Estradiol 100
Levonorgestrel 500
Can substitute with any OCP with same dose of estrogen
Yuzpe method
Within 72 h Up to 5 d 2 tabs, repeat in 12 h Contra: no absolute Caution if contra to OCP
Plan B formulation
Levonorgestrel 750
Plan B method
1 tab, repeat after 12 h
Within 72 h
Up to 5 d
No caution for contra to OCP
Choice ECP after 24 h
Plan B
Plan B not recommended for
> 80 kg
Ulipristal method
30 mg PO within 5 d
No caution in OCP contra
EPC with IUD
Copper
Up to 7 d
Mirena cannot be used
1st line contraceptive for adolescents
Implants, IUDs, that do not affect BMD
F/U on EPC
In 3-4 wk
Beta test or spontaneous mense
Contra counseling
Gold std medical method of abortion up to 9 wk
Mifepristone + misoprostol
Medical methods of abortion
- mifepristone+ misoprostol
- misoprostol aline
- MTX+misoprostol
Surgical abortion methods
<14 wk
•manual vacuum aspiration (up to 8-9wk)
•suction dilation+ aspiration+/- curettage +/- presurgical preparation of cervix (laminaria, misoprostol)
14-24 wk
•Dilatation + evacuation + presurgical cervix preparation + pain management
Septic spontaneous abortion Tx
IV AB 24h
Then uterine evacuation
Embryonic demise
CRL 7 mm or more and no cardiac activity
Most common location for EP
Ampullary
Most common etiology of EP
PID (chlamydia Trachomatis)
Suspected EP
Urine beta
Unstable EP (+ urine beta)
Surgery
Stable EP
TVS
Serum beta
Surgical management if any of:
- > 3.5 cm
- beta>5000
- renal/liver/hemato disease
- FHR present
- poor compliance
- unable to F/U
MTX for EP if
- <3.5 cm and
- beta> 5000 and
- no FHR and
- no renal/hepatic/hemato disease and
- compliance assured and
- able and willing to F/U and
- no pulmonary disease/PUD/ immunodeficiency and
- no pregnancy/lactation
Investigation for EP
Serial beta:
If rise <20 %, non viable
If prolonged doubling, plateau, decreasing before 8 wk, non viable
U/S:
Tubal ring (specific)
If beta>2000-3000 and empty uterus by TVS, suspect ectopic
Definitive if FHR in tube
Normal beta doubling time
1.6-2.4 d
Surgical options
•Laparoscopy:
Linear salpingostomy, then weekly beta
Salpingectomy if tube damaged/ipsilateral recurrence, then weekly beta
- Laparotomy if unstable/extensive surgical Hx
- If Rh negative, Rhogam
Medical Tx for EP
MTX 50/m2 IM single dose
Then weekly beta
2nd dose of MTX if
Beta not decreased by at least 15% between days 4-7 (in 25% of cases)
Tubal potency after MTX for EP
80%
Mx of abortion
R/O EP
Check Rh
Ensure stability
Wait and watch or misoprostol or D&C
Prenatal DES exposure
Infertility with uterine factors
Clear cell adenocarcinoma of vagina
Infertility female tests
•ovulatory -Day 3: FSH,LH,estradiol, TSH, PRL, +/- DHEA, FreeTest -Day21-23: serum progesterone -basal body temperature monitoring -postcoital test (mucus:clarity, PH, spinnbarkeit/fibrosity) •peritoneal/uterine factors HSG/SHG, hysteroscopy •tubal factors HSG/SHG Laparoscopy with dye insufflation •other Karyotype
When to investigate for infertility
<35y, after 1 y
35-40, after 6mo
>40, immediately
Earlier investigation if
Hx of PID Hx of infertility with previous partner Hx of pelvic surgery Hx of chemo/RT Hx of recurrent pregnancy loss Mod-severe endometriosis
Proper intercourse timing
From 2 d prior to 2 d following presumed ovulation, every other day
Ovulation induction methods
•Clomiphene citrate then beta •letrozole \+/- bromocriptine (if high PRL) dexa (adult onset CAH) Metformin (PCOS) Prog supplementation during luteal Anticoagulation/ASA (Hx of recurrent spontaneous abortion, APLS) Thyroid replacement (keep TSH< 2.5)
Normal semen
Abstinence: 2-7d Volume: 1.5cc Count:15 million/cc Vitality:58% Motility:40% Progressive:32% Normal morphology:40%
Criteria for PCOS
Oligomenorrhea/irregular menses for 6 mo
Hyperandrogenism(clinical or free test)
PCO on U/S
PCOS in adolescence
Polycystic ovaries on U/S not an appropriate criteria
Wait 1-2 y before Dx
Aim of investigations for PCOS
identify hyperandrogenism
Identify chronic anovulation
R/O pituitary or adrenal cause
Tests for PCOS
LAB:
PRL, TSH, Free T4,
17-oh-prog, DHEA-S, free testo (most sens), androstenedione, SHBG (decreased)
LH:FSH> 2
U/S (TVS, transabdo): string of pearls (12 or more follicles) or increased ovarian volume
Insuline resistance: fasting glucose:insuline <4.5
IGT: 75 g OGTT yearly
Cycle control in PCOS
Lifestyle: exercise, decrease BMI
OCP, MPA (to prevent endometrial hyperplasia)
Metformin: if DM2, trying pregnancy
Tranex: menorrhagia
Infertility Tx in PCOS
Induction of ovulation: clomiphen citrate, letrozole, HMG, LHRH, recombinant FSH, metformin
Ovarian drilling, wedge resection
Bromocriptine, if hyperPRL
Tx of hirsutism in PCO
OCP
Mechanical removal
Finasteride, flutamide, spironolactone
Normal discharge pH
3.8-4.2
Prepubertal vulvovaginitis investigation
Vaginal swab for culture (state the age)
pH, wet mount, KOH (for adults)
Etiology of vaginal bleeding in prepubertal vulvovaginitis
GAS
Shigella
Endocrine abnormality
Blood dyscrasia
Most common prepubertal gynecological problem in girls
Non-specific vulvovaginitis
RFs of candida vulvovaginitis
Diaper
Chronic AB
Chronic immunosuppression
Vulvovaginitis due to increased estrogen levels
Candida
Cottage cheese discharge
Candida
Asymptomatic candidiasis VV
20%
VV with intense pruritus
Candida
pH in VV candidiasis
4.5 or less
VV candidiasis Tx in pregnancy
Usually topical
Can use fluconazole 150 single dose
Prophylaxis for recurrent candidiasis VV
Boric acid
Vaginal suppositories
Luteal phase fluconazole
Partner in candidiasis?
Routine Tx not needed
Discharge in BV
Grey, thin, diffuse,
Fishy odor
BV
Asymptomatic BV
50-70%
Absence of irritation
BV
pH in BV
4.5 or more
Clue cells
BV (squamous dotted with coccobacilli)
20%
Paucity of WBC in discharge
BV
Paucity of lactobacilli
BV
Positive whiff test
BV
TV
BV Tx indications
Pregnancy
Symptomatic
Pelvic surgery/procedure
Tx of BV
Metro 500 PO BID x 7d
Metro gel OD x 5d
Clinda intravaginal x7d
Probiotics oral or topical (lactobacillus)
Tx of partner in BV?
No
Obstetric complications of BV
Preterm labour
Postpartum endometritis
BV Tx in pregnancy
Topical metro
Oral metro?
Missed MPA
If last injection given 13-14 wk prior, give next immediately
If >14 wk prior, check beta
Petechiae on cervix and vagina
Trichomonas vaginalis
VV with sexual transmission
TV
Discharge in TV
Yellow-green, malodorous, diffuse, frothy
Asymptomatic TV
25%
pH in TV
4.5 or more
Flagellated organism on wet mount
TV
Many WBC/PMN
TV
Treatment indications
All
Tx of TV
Metro 2g PO single dose
Metro 500 bid x 7d
Tx of TV in pregnancy
Metro 2g once
Partner in TV
Should treat
Detection of HPV latent infection
DNA hybridization test
Subclinical HPV infection detection
Colposcopy
Pap-smear
Tx of HPV
Podofilox 0.5% bid x3d/wk in a row x 4wk Imiquimod 5% 3x/wk qhs x16 wk Podophyllin resin in tincture of benzoin weekly TCA weekly Cryo q1-2 wk Surgery/ laser Cryo IL IFN
HPV Tx in pregnancy
TCA 80-90%
HSV incubation
2-21d (7-10d)
HSV detection
Viral culture if ulcer present
Tzanck
HSV DNA PCR
Serologic tests
Indication of C-section in genital wart
Obstruction of birth canal
Risk of extensive bleeding
Condyloma in pregnancy
Tend to get larger
Should be treated early
HSV Tx
Education (avoid contact since prodrome until clearance of lesions, barrier)
1st episode: acyclo, famcyclo, valacyclo 7-10 d
Recurrent episode: 2-5d
More than 6 recurrence/y: suppressive Tx
Severe disease: IV acyclo until clinical improvement, then oral to complete 10 d
Most Sn/Sp test for syphilis
Darkfield microscopy
Syphilis tests negative after treatment:
VDRL, RPR
Syphilis Tx
Primary/secondary/latent of<1y duration:
Benzathine penicillin G 2.4 m IM single dose
Latent>1y duration:
Benzathine penicillin G 2.4 m IM/wk x3 wk
Neurosyphilis:
Aqueous penicillin G 4m q 4h x 10-14d
Partner in syphilis?
Screen and treat
Most common genital ulcer
HSV
2nd most common genital ulcer
Syphilis
Most common bacterial STI
Chlamydia Trachomatis
Asymptomatic chlamydia
80% of women
Discharge in chlamydia
Mucopurulent, endocervical
Urethral symptoms
Candida
TV
Chlamydia
HSV
CDC notifiable diseases
Chancroid Chlamydia Gonorrhea Hepatitis A,B,C HIV Syphilis
Missed MPA+ positive beta
EPC
And no injection
Intermenstrual bleeding
Polyp
Chlamydia (particularly if on OCP)
Endometrial carcinoma
Chlamydia Dx
Cervical culture/nucleic acid amplification test
Definitive std: tissue culture
Urine/self vaginal tests
(Urine culture negative, but pyuria)
Tx of Chlamydia
Doxy 100 PO bid x7d
Azithro 1g PO single dose
+ gonorrhea Tx
Partner in chlamydia?
Treat
Chlamydia in pregnancy
Azithro
Test of cure required in 3-4 wk
Screening for chlamydia
When initiating OCP in sexually active
High risk group
Pregnancy
Organism that needs to be screened for when initiating OCP
Chlamydia
Hepatic complication of chlamydia
Fitz-Hugh-Curtis (liver capsule inflammation)
Gonorrhea Dx
Gram stain
Cervical/rectal/throat culture (if clinically indicated)
Tx of gonorrhea
Ceftriaxone 250 IM single + azithro 1g
Tx of gono in pregnancy
Ceftriaxone 250 + azithro 1g
Spectinomycin 2g IM + azithro 1 g
STI testing
Vaginal swab: candida, BV,TV
Cervical swab: gono, chla
Indications of test of cure for gono/chla
Symptomatic
Uncertain compliance
Pregnant
Bartholin gland abscess microorganisms
Anaerobic, polymicrobial
Bartholin Tx
Sitz bath Warm compress Cephalexin + I&D + Word cath 2-3wk Marsupialization Remiving gland
Most common cause of PID
Chlamydia
Gonorrhea
Cause of recurrent PID
Endogenous flora
Cause if PID associated with instrumentation
Endogenous flora
Organism associated with IUD
Actinomyces israelii (not the most common cause of course!)
How long does IUD increase the risk of PID?
10 d
Asymptomatic PID
2/3
Most common etiology of chronic PID
Chlamydia
PID investigations
Beta CBC B/C (if suspect septicemia) Urine R&M Vaginal swab Cervical swab Definitive Dx: endometrial Bx U/S Laparoscopy (gold std)
The must have symptom for Dx of PID
Lower abdominal pain
Required signs for Dx of PID
Cervical morion tenderness
Or
Adnexal tenderness
Tx of PID
polymicrobial coverage
Tx in case of admitted PID
Cefoxitin+ doxycycline
Or
Clindamycin+ gentamycin
All IV until 24 h after symptoms have resolved
Then, PO doxy bid to complete 14 d
+ percutaneous abscess drainage with U/S guide
(If no response, laparoscopic drainage)
If failure, surgery (TAH/BSO)
Outpatient Tx of PID
Ceftriaxone 250 IM x 1 + doxy 100 bid x 14 d +/- metronidazole 500 bid x14d
Or
Cefoxitin 2g IM + probenecid 1g PO x1 + doxy 100 bid x 14d +/- metro bid x14d
Or
Ofloxacin bid x14d +/- metro bid x14d
Or
Levofloxacin bid x14d +/- metro bid x14d
F/U in 48-72 h
If pt not tolerant of cephalo and Q, azithro + metro
IUD removal in PID
After a minimum of 24 h of treatment
Partner treatment in PID?
Yes
Report PID?
Yes
Re-testing for PID?
For chlamydia/gonorrhea 4-6 wk ofter treatment if documented infection
Foreign body duration for TSS
> 24h
TSS Tx
Remove potential source of infection Debride necrotic tissue Hydration Penicillinase-resistant AB (cloxacillin) Steroid within 72 h
Pelvic cellulitis
Post hysterectomy
Tx if: fever, leukocytosis
Tx: clinda+genta
+ drain if excessive purulence/large mass
Dietary changes for vestibulitis
Increased citrate
Decreased oxalate
Menopause definition
Lack of menses for 1 y
Average age:51
Primary ovarian insufficiency
Before age 40
Menopause Dx
Use:absence of menses for 1 y
FSH (day 3) > 35
Increased LH
Decreased estradiol
Vasomotor instability Tx
1st line: HRT (low dose, short duration < 5y)
Others: SSRI, venlafaxin, gabapentin, clonidine, propranolol, acupuncture
Vaginal atrophy Tx
Local estrogen
Lubricant
HRT
Laser
Urogenital health
Lifestyle: weight loss, bladder re-training, local estrogen, surgery
Osteoporosis
1000-1500 mg Ca/d 800-1000 unit Vit D Weight-bearing exercise Smoking cessation Bisphosphonate SERM: raloxifene 2nd line: HRT
Raloxifene
Estrogen effect on bones
No effect on breast/uterine
Decreased libido
Lubrication
Counseling
Testosterone cream
CVD Tx
RF Mx
Absolute contraindication of HRT!
Mood and memory
1st line: anti-depressant
HRT
Perimenopause
2-8 y preceding to 1 y after last mense
Fluctuating hormones
Irregular menses
Symptom onset
Breast cancer risk with hormonal therapy:
Increased if estrogen + progesterone
Not increased with estrogen-only HRT
Preferred HRT route
Transdermal
Especially if hyper TG, impaired hepatic function, smoker, headache with oral HRT
Bleeding episode in a post-menopausal amenorrheic woman on OCP
Endometrial Bx
HRT with PMS symptoms
Std dose cyclic
HRT and cognitive impairment
Increased cognitive impairment if taken after 65 y (combined> estrogen only)
Reduced risk of dementia if taken < 65y
Benefits of HRT
Vasomotor
Osteoporosis
Colon cancer
Gynecological cancer whose RF in diabetes
Type I and II endometrial carcinoma
Cancer with Tamoxifen
Endometrial, type 1
Abn endometrial thickness in post-menopause women with AUB
5mm or more
Uterus size in endometrial carcinoma
Normal
If endometrial carcinoma suspected
Endometrial Bx
D&C +/- hysteroscopy
+/- pelvic U/S (if adequate sampling not feasible)
U/S role in endometrial carcinoma
Not suitable for screening test
Not acceptable as alternative to pelvic exam or endometrial Bx to R/O cancer
Endometrial carcinoma Tx
1st step: TAH/BSO
+ pelvic washing
+/- pelvic/para-aortic node dissection
+/- omentectomy
Better QOL if laparoscopic
Adj RT for Endometrial carcinoma
If high risk of local recurrence
Adj chemo for endometrial carcinoma
If mets
Or
High risk of mets (based on histologic findings)
Chemo for endometrial cancer
If recurrent disease (if high grade)
Hormonal therapy for endometrial carcinoma
Progestin
For recurrent disease (if low grade)
Most important prognostic factor in endometrial carcinoma
FIGO stage
Post-menopausal woman with rapidly enlarging uterus
Consider leiomyosarcoma
Perform an endometrial Bx
Tx differences between leiomyosarcoma and endometrial carcinoma
No routine LND
No role for RT
Cancer increased by fertility drugs
Ovarian epithelial carcinoma
Drug reducing risk of ovarian cancer
OCP
Marker of epithelial cell tumor
CA-125
Granulosa cell tumor marker
Inhibin
Sertoli-Leydig tumor marker
Androgens
Dysgerminoma marker
LDH
Yolk sac tumor marker
AFP
Choriocarcinoma
Beta
Immature teratoma marker
None
Embryonal cell marker
AFP
Beta
Omental cake
Ovarian cancer
Mass screening for endometrial cancer
No
Mass screening for ovarian cancer
No
Indications of screening for ovarian cancer
- > 1 1st degree relative with ovarian cancer, BRCA1 mutation
- Hx of endometrial/breast/colon cancer
- BRCA1/2 mutation
Method of screening
CA-125
TVS
Starting age:30
If BRCA1/2 mutation
Prophylactic bilateral oophorectomy after age 35/after completed child bearin
Symptomatic/suspicious adnexal mass
Sugical exploration
Follicular mass U/S
4-8 cm
Unilacular
Follicular mass Mx
If not suspicious/asymptomatic and <6cm :
Wait 6 wk + OCP
If no regression: laparoscopy
Corpus luteum vs follicular cyst
Corpus luteum more likely to cause pain, may delay onset of next period, larger(10-15cm) , firmer
Mx of corpus luteum cyst
Same as follicular
Cyst generated by abn beta levels
Theca-Lutein
eg: molar pregnancy, clomiphene
Drug causing theca-lutein cyst
Clomiphene
Mx of theca-lutein cyst
Conservative
Treat high beta levels
The most common ovarian germ cell neoplasm
Dermoid (cystic teratoma)
Pathognomonic finding in benign teratoma
Calcification
Tx of dermoid cyst
Laparoscopic cystectomy
Tumors for which total resection is not necessary due to high response rate to chemo
Dysgerminoma
Immature teratoma
Most common ovarian tumor
Serous
Psamomma body
Serous
Pseudyxoma peritonitis
Mucinous
Enormous size
Mucinous
Need to remove appendix
Mucinous
Poor response to chemo
Mucinous
Meig’s syndrome (benign ovarian tumor and ascitis and pleural effusion)
Fibroma/thecoma
Ovarian tumor associated with endometrial cancer
Granulosa-theca cell tumor
Precocious puberty
Granulosa-theca (estrogen)
Postmenopausal bleeding
Granulosa-theca
Menorrhagia
Granulosa-theca
Call-exner bodies in histology
Granulosa-theca
Virilizing effects
Sertoli-Leidig
Krukenberg
Metastatic ovarian tumor from stomach/colon/breast source
Signet ring cells
Investigations for ovarian cancer
Bimanual exam
Risk of Malignancy Index (RMI, used for referral)
CA-125, CBC, LFT, lytes, creatinine
TVS
CT abdomen, pelvis
If suspicious of other primary sources:
FOB, if positive, endoscopy +/- barium enema
If gastric symptoms: gastroscopy +/- upper GI series
If AUB: endometrial Bx
If abn cervix: cervix Bx
If breast lesion/RF: mammogram
Nabothian cyst
Benign cervical ct
Gynecological malignancy with smoking RF
Cervical
Barrel-shaped cervix
Adenocarcinoma
Normal Pap
Repeat in 1-3 yr
Inadequate sample
Repeat in 3 mo
Pap: ASCUS
Age?
30 or higher: HPV-DNA testing
Less than 30: repeat pap in 6 mo
ASCUS, above 30, positive HPV-DNA test
Colpo
ASCUS, below 30, repeated in 6 mo: ASCUS
Colpo
ASCUS, above 30, negative HPV
repeat cytology in 12 mo
ASCUS, below 30, negative repeated cytology after 6 mo, next step?
Repeat cytology in 6 mo
ASCUS, below 30, negative repeated cytology, negative again after another 6 mo
Routine screen in 3 year
ASCUS, below 30, negative ctopogy in 6 mo, ASCUS in 3rd cytology in 6 mo
Colpo
ASC-H
Colpo
AGUS
Colpo +/- endometrial Bx
LSIL
Either colpo or repeat cytology in 6 mo
LSIL, negative after 6 mo
Repeat in 6 mo
LSIL, if ASCUS or more after 6 mo
Colpo
LSIL, negative in 6 mo, again negative in 6 mo
Routine screening in 3 years
LSIL, negative in 6 mo, but ASCUS or more in 2nd repeat in 6 mo
Colpo
HSIL
Colpo
Any malignant changes on Pap
Colpo
Marker for monitoring ovarian cancer response to treatment
CA-125
Cold knife conization indication
Suspicion of glandular abnormality
Indications for LEEP
Unsatisfactory colpo
Discrepancy between cyto/colpo/histo
Glandular abnormality in endocervical curettage
Suspicious of adenocarcinoma in situ
Recurrence of lesion post-ablation/excision
Inability to R/O invasive disease
Gardasil age
Females: 9-45
Males: 9-26
Cervarix age
Females 10-25
Conception after HPV vaccin
Avoided until 30 days
Endocervical curettage indication
No lesion on colpo
Entire lesion not visible
Pap in pregnancy
At all initial prenatal visits
Time of diagnostic conization during pregnancy
2nd trimester
Dysplasia Mx during pregnancy
Deferred until completion of pregnancy
Delivery mode in presence of dysplasia
Vaginal
Invasive cervical cancer in pregnancy
Mx depends on prognosis, fetal maturity, pt wishes
T1: termination+ radical surgery or chemoradio
T2/T3: delay therapy until viable fetus, then C/S + concurrent radical surgery or subsequent chemoradio
CIN I Mx
Observation
Repeat assessment and cytology in 12 mo
If cytology: HSIL/AGC
And then: CIN
Review of cytology and histology
If discrepancy remains, excisional Bx
If CIN II/III
Age 25 or higher: treat ( excision preferred for CIN III)
Positive margin: F/U with colpo +/- Bx/endocervical curettage
Age <25: observe with colpo q 6 mo for 24 mo (then consider Tx)
Pregnancy: treatment and repeat colpo 8-12 wk after delivery
Age of hyperplastic dystrophy of vulva
Post menopausal
Tx of hyperplastic dystrophy
CS oint
Most common age of lichen sclerosis
Post menopausal
VIN Tx
Local excision
Ablation
Imiquimod
Most important predictor of prognosis in vulvar cancer
Nodal involvement
2nd most important: tumor sizea
Schiller test
For Dx of abn squamous epithelium of vagina (doesn’t take up Lugol)
Most common site of vaginal SCC
Upper 1/3 of posterior wall
Vitamin deficiency implicated in mole formation
Vit A
B-carotene
The most common symptom of complete mole
Vaginal bleeding
Complete mole chromosome
XX, XY
Incomplete mole chromosome
XXX, XXY, XYY
Risk of malignant sequelae for complete mole
15-20%
Risk of malignant sequelae for incomplete mole
<4%
Presentation of incomplete mole
Threatened/spontaneous/missed abortion
Mole investigation
Beta
U/S
CXR
U/S of complete mole
Snow storm
U/S of incomplete mole
Degeneration of placenta
Multiple echogenic regions
Fetal abnormalities
High risk of persistent GTN following mole evacuation
Uterine invasion as high as 31%
Beta >100000
Excessive uterine size
Prominent theca-lutein cyst
Mole Tx
Suction D&C with sharp curettage
+oxytocin
+Rhogam
Consider: histerectomy
F/U of mole
Contraception during entire F/U
period
Serial beta, weekly, until negative x3, then monthly for 6-12 mo
If increase or plateau of beta, chemol
HTN <20 wk in pregnancy
Think GTD/GTN
GTN with relative insensitivity to chemo
Placental site trophoblastic tumor
Features of bad prognosis in metastatic GTN
Long duration from pregnancy (>4mo) Beta>100,000/24h urine Beta>40,000/ blood Brain/liver mets Prior chemo Following term pregnancy
GTN investigation
CBC, lytes, Cr, beta, TSH, LFT
CXR, U/S pelvis, CT abdo/pelvis, CT brain
If suspect brain mets, but negative CT
LP:
If plasma beta/CSF beta <60: mets
Stage 1 GTN Tx
Confined to uterine corpus
Stage 2: mets to genital
Stage 3: mets to lungs
•if low risk: pulsed actinomycin (1st line)
Alternative: MTX
•if high risk: combination chemo
Stage 4 GTN
Mets to brain, liver, kidney, GI tract
Combination chemo
+ surgical resection of sites of disease persistence, resistance to chemo
+/- RT for brain mets
No1 place for GTN mets
Lungs
F/U for GTN
Contraception during entire f/u period
Stage1,2,3: weekly beta until 3 negative, then monthly x12 mo
Stage4: weekly beta until 3 negative,
Then monthly x 24mo
GTN Dx
Plateau: <10% drop over 4 values in 3wk
Rise: >20% in any two values over 2wk or longer
Persistent elevation >6 mo
Mets on w/u